Diversified Product Portfolio

Product Grade Commercially Available Under Development
Acotiamide HCI Hydrate IH Yes
Apremilast IP/IH Yes
Dantrolene sodium USP/IH Yes
Flupirtine Maleate IH Yes
Iguratimod IH Yes
Ivabradine Hydrochloride IH Yes
Levodropropizine IP/BP/EP/IH Yes
Levonadifloxacin IH Yes
Linagliptin IH Yes
Mirabegron IP/EP/IH Yes
Nadifloxacin IP/IH Yes
Olmesartan Medoxomil BP/EP/USP/IP/IH Yes
Omadacycline Tosylate IH Yes
Pidotimod IH Yes
Relugolix IH Yes
Rosuvastatin Calcium BP/EP(CEP Grade)/USP/IP/IH Yes
Roxadustat IH Yes
Silodosin IH/JP Yes
Ticagrelor IP/EP/BP Yes
Tigecycline IH/EP/USP Yes
Tofacitinib Citrate IP/IH Yes
Tolvaptan IH Yes
Triclofos Sodium IP/IH Yes
Dotinurad IH Yes
Gadobutrol IH Yes
Perindopril IH/EP Yes
Resmetirom IH Yes
Samidorphan IH Yes
Sparspentan IH Yes
Tribenoside IH Yes

Intermediate List

IUPAC Name CAS Number End API
(R)-1-(1-(3-(benzoyloxy)propyl)-7-cyanoindolin-5-yl) propan-2-aminium (2S,3S)-3-carboxy-2,3-dihydroxypropanoate 2090120-00-4 Silodosin
2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl methanesulfonate 160969-03-9 Silodosin
(R)-2-hydroxy-N-(4-nitrophenethyl)-2-phenylacetamide 521284-19-5 Mirabegron
(R)-2-((4-nitrophenethyl)amino)-1-phenylethanenol 223673-34-5 Mirabegron
(R)-2-((4-nitrophenethyl)amino)-1-phenylethanol hydrochloride 521284-21-9 Mirabegron
(R)-2-[[2-(4-aminophenyl)ethyl]amino]-1-phenylethanol 391901-45-4 Mirabegron
(R)-2-[[2-(4-aminophenyl)ethyl]amino]-1-phenylethanol hydrochloride 521284-22-0 Mirabegron
7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one 73942-87-7 Ivabradine
(1S)-4,5-dimethoxy-1-[(methylamino)methyl] benzocyclobutanehydrochloride 866783-13-3 Ivabradine
Disclaimer: Patented products are available for R&D purposes only as permitted under 35 U.S.C. Section 271 (e) (I).